Follow
Marc Fakhoury
Marc Fakhoury
Verified email at lau.edu.lb - Homepage
Title
Cited by
Cited by
Year
Inflammatory bowel disease: clinical aspects and treatments
M Fakhoury, R Negrulj, A Mooranian, H Al-Salami
Journal of inflammation research, 113-120, 2014
5782014
Microglia and astrocytes in Alzheimer's disease: implications for therapy
M Fakhoury
Current neuropharmacology 16 (5), 508-518, 2018
4222018
Autistic spectrum disorders: A review of clinical features, theories and diagnosis
M Fakhoury
International journal of developmental neuroscience 43, 70-77, 2015
2972015
Revisiting the serotonin hypothesis: implications for major depressive disorders
M Fakhoury
Molecular neurobiology 53, 2778-2786, 2016
2292016
Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases
M Fakhoury
Neurodegenerative Diseases 15 (2), 63-69, 2015
1162015
Spinal cord injury: overview of experimental approaches used to restore locomotor activity
M Fakhoury
Reviews in the Neurosciences 26 (4), 397-405, 2015
1112015
The habenula in psychiatric disorders: more than three decades of translational investigation
M Fakhoury
Neuroscience & Biobehavioral Reviews 83, 721-735, 2017
852017
Role of the endocannabinoid system in the pathophysiology of schizophrenia
M Fakhoury
Molecular neurobiology 54, 768-778, 2017
792017
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, TK Mukkur, ...
Drug design, development and therapy, 1221-1230, 2014
772014
New insights into the neurobiological mechanisms of major depressive disorders
M Fakhoury
General hospital psychiatry 37 (2), 172-177, 2015
612015
Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
R Negrulj, A Mooranian, N Chen-Tan, HS Al-Sallami, M Mikov, ...
Artificial cells, nanomedicine, and biotechnology 44 (5), 1290-1297, 2016
592016
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, T Mukkur, ...
Drug design, development and therapy, 1003-1012, 2014
562014
Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment
A Mooranian, R Negrulj, N Chen-Tan, M Fakhoury, F Arfuso, F Jones, ...
Artificial cells, nanomedicine, and biotechnology 44 (2), 588-595, 2016
552016
Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes
A Mooranian, R Negrulj, HS Al-Sallami, Z Fang, M Mikov, ...
Aaps Pharmscitech 16, 45-52, 2015
532015
Drug delivery approaches for the treatment of glioblastoma multiforme
M Fakhoury
Artificial cells, nanomedicine, and biotechnology 44 (6), 1365-1373, 2016
522016
Could cannabidiol be used as an alternative to antipsychotics?
M Fakhoury
Journal of psychiatric research 80, 14-21, 2016
482016
Immune-mediated processes in neurodegeneration: where do we stand?
M Fakhoury
Journal of neurology 263, 1683-1701, 2016
482016
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
A Mooranian, R Negrulj, HS Al-Sallami, Z Fang, M Mikov, ...
Journal of microencapsulation 32 (2), 151-156, 2015
472015
Artificial intelligence in psychiatry
M Fakhoury
Frontiers in Psychiatry: Artificial Intelligence, Precision Medicine, and …, 2019
462019
The lateral hypothalamus: an uncharted territory for processing peripheral neurogenic inflammation
M Fakhoury, I Salman, W Najjar, G Merhej, N Lawand
Frontiers in neuroscience 14, 101, 2020
412020
The system can't perform the operation now. Try again later.
Articles 1–20